Last Price$3.28NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/21/22

Today's Change-0.28(7.87%)
Bid (Size)$3.25 (27)
Ask (Size)$3.27 (1)
Day Low / High$3.18 - 3.46
Volume16.6 M

View Biotechnology IndustryPeer Comparison as of 01/21/2022


Ocugen Inc ( NASDAQ )

Price: $3.28
Change: -0.28 (7.87%)
Volume: 16.6 M
4:00PM ET 1/21/2022

Agenus Inc ( NASDAQ )

Price: $2.68
Change: -0.06 (2.19%)
Volume: 4.0 M
4:00PM ET 1/21/2022

MeiraGTx Holdings PLC ( NASDAQ )

Price: $15.44
Change: -0.32 (2.03%)
Volume: 199.3 K
4:00PM ET 1/21/2022

Seres Therapeutics Inc ( NASDAQ )

Price: $7.51
Change: -0.11 (1.44%)
Volume: 869.9 K
4:00PM ET 1/21/2022

Rubius Therapeutics Inc ( NASDAQ )

Price: $7.30
Change: -0.40 (5.19%)
Volume: 681.9 K
4:00PM ET 1/21/2022

Read more news Recent News

Ocugen Says Data Show Covaxin Booster Neutralizes SARS-CoV-2 Omicron, Delta Variants
8:23AM ET 1/12/2022 MT Newswires

Ocugen (OCGN) said Wednesday a recent study has shown a booster dose of its candidate vaccine, Covaxin, generated robust neutralizing antibody responses...

Ocugen's Covaxin Booster Shot Increased Antibody Levels by Over 10-fold, Phase 2 Results Show
4:36AM ET 1/10/2022 MT Newswires

Ocugen (OCGN) said Saturday that a booster shot of its COVID-19 vaccine Covaxin increased antibody levels by more than a 10-fold across numerous variants...

Sector Update: Health Care Stocks Holding Onto Midday Gains
4:11PM ET 12/30/2021 MT Newswires

Health care stocks largely held on to their midday gains this afternoon, with the NYSE Health Care Index rising 0.5% while the SPDR Health Care Select...

Sector Update: Health Care Stocks Outpacing Dow, S&P 500 to the Upside
1:59PM ET 12/30/2021 MT Newswires

Health care stocks were moderately higher this afternoon, with the NYSE Health Care Index rising 0.4% and the SPDR Health Care Select Sector ETF (XLV) up...

View all Commentary and Analysis

Ocugen: Time Is Running Out
8:58AM ET 12/08/2021 Seeking Alpha

IBB And XBI: 4 Reasons To Buy Biotech Stocks Ahead Of 2022
8:33AM ET 12/06/2021 Seeking Alpha

Ocugen Stock Is A Highly Speculative Play For Aggressive Investors Only
3:29AM ET 11/11/2021 Seeking Alpha

Ocugen, Inc. 2021 Q3 - Results - Earnings Call Presentation
2:39PM ET 11/09/2021 Seeking Alpha

Company Profile

Business DescriptionOcugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA. View company web site for more details
Address263 Great Valley Parkway
Malvern, Pennsylvania 19355
Number of Employees49
Recent SEC Filing01/20/20224
Chairman & Chief Executive OfficerShankar Musunuri
CFO, Secretary & Head-Corporate DevelopmentSanjay Subramanian
Vice President-Research & DevelopmentArun Upadhyay
Chief Medical OfficerBruce D. Forrest

Company Highlights

Price Open$3.45
Previous Close$3.56
52 Week Range$1.40 - 18.77
Market Capitalization$653.3 M
Shares Outstanding199.2 M
SectorHealth Technology
Next Earnings Announcement03/17/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.25
Beta vs. S&P 500N/A
Net Profit MarginN/A
Return on Equity-65.27%

Analyst Ratings as of 12/16/2021

Consensus RecommendationConsensus Icon
Powered by Factset